148 related articles for article (PubMed ID: 11115235)
1. Transgenic mouse models and human neurodegenerative disorders.
Deng HX; Siddique T
Arch Neurol; 2000 Dec; 57(12):1695-702. PubMed ID: 11115235
[No Abstract] [Full Text] [Related]
2. [Approaches from genetical analyses on human diseases: neurodegenerative diseases].
Kakizuka A
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):792-7. PubMed ID: 10771635
[No Abstract] [Full Text] [Related]
3. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
Jankowsky JL; Savonenko A; Schilling G; Wang J; Xu G; Borchelt DR
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):457-64. PubMed ID: 12169227
[TBL] [Abstract][Full Text] [Related]
4. Genetic neurodegenerative diseases: the human illness and transgenic models.
Price DL; Sisodia SS; Borchelt DR
Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
[TBL] [Abstract][Full Text] [Related]
5. Toxic proteins in neurodegenerative disease.
Taylor JP; Hardy J; Fischbeck KH
Science; 2002 Jun; 296(5575):1991-5. PubMed ID: 12065827
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis as a general cell death pathway in neurodegenerative diseases.
Offen D; Elkon H; Melamed E
J Neural Transm Suppl; 2000; (58):153-66. PubMed ID: 11128605
[TBL] [Abstract][Full Text] [Related]
7. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
8. What transgenic mice tell us about neurodegenerative disease.
Gurney ME
Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
[TBL] [Abstract][Full Text] [Related]
9. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
Ebert S; Goos M; Rollwagen L; Baake D; Zech WD; Esselmann H; Wiltfang J; Mollenhauer B; Schliebs R; Gerber J; Nau R
J Neurosci Res; 2010 Apr; 88(5):1124-36. PubMed ID: 19859962
[TBL] [Abstract][Full Text] [Related]
10. [Diseases associated with protein aggregation].
Bak D; Milewski M
Postepy Biochem; 2005; 51(3):297-307. PubMed ID: 16381174
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure of prion protein: implications for prion disease.
Baldwin MA; James TL; Cohen FE; Prusiner SB
Biochem Soc Trans; 1998 Aug; 26(3):481-6. PubMed ID: 9765900
[No Abstract] [Full Text] [Related]
12. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
13. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
14. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
15. [Neurology. Therapeutic advances through systems research and molecular biology].
Hohlfeld R; Brandt T
Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1577-81. PubMed ID: 10664661
[No Abstract] [Full Text] [Related]
16. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
17. Transgenic invertebrate models of age-associated neurodegenerative diseases.
Link CD
Mech Ageing Dev; 2001 Sep; 122(14):1639-49. PubMed ID: 11511401
[TBL] [Abstract][Full Text] [Related]
18. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
19. Transgenic models of neurodegenerative diseases.
Lee MK; Borchelt DR; Wong PC; Sisodia SS; Price DL
Curr Opin Neurobiol; 1996 Oct; 6(5):651-60. PubMed ID: 8937830
[TBL] [Abstract][Full Text] [Related]
20. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
